# Case 3 — Pyxis next-dispense: answer lost in 66 tool calls

**qid:** `ehr_bench_decision_making_11698` · **task:** `pyxis`
**gold:** `['Piperacilli 4.5g/100mL 100mL BAG']`

- **ClinSeek final** ❌: `['MetroNIDAZ 500mg/100mL 100mL BAG']` (tool calls = 66, messages = 107)
- **Reasoning final** ✅: `['Piperacilli 4.5g/100mL 100mL BAG']` (tool calls = 1, messages = 3)

## Tool-call distribution

**ClinSeek:**
```
  ehr.run_sql_query                        41
  ehr.get_records_by_time                  12
  ehr.get_column_names                     3
  ehr.get_latest_records                   3
  ehr.load_ehr                             1
  ehr.get_table_names                      1
  ehr.get_records_by_value                 1
  browser.search                           1
  browser.open                             1
  ehr.think                                1
  ehr.finish                               1
```

**Reasoning pipeline:**
```
  ehr.finish                               1
```

## Why the paradigms diverge

- The reasoning-mode prompt lists the Pyxis dispense sequence chronologically. The obvious next-dispense is piperacillin; reasoning-mode Opus answered correctly.
- ClinSeek (Opus) went wide instead of local: 66 tool calls across microbiology, labs, diagnoses, and browser searches for empiric antibiotic guidelines. It inferred metronidazole (anaerobic coverage) — a plausible but wrong clinical step.

## Vital ClinSeek tool calls (the calls that led the agent to its wrong answer)

### 1. [MISLEADING] Call #38: `ehr.run_sql_query` — MetroNIDAZOLE administered during prior admission (hadm_id 23137539) on 2158-06-30

**Why this call determined the answer:** Agent used prior admission's metronidazole use to infer it would be the next pyxis dispense, ignoring current visit's actual pyxis data.

_Tool call:_ `ehr.run_sql_query({"subject_id": "14290863", "sql_query": "SELECT medication, charttime, event_txt FROM emar WHERE hadm_id = 23137539.0 ORDER BY charttime LIMIT 30"})`

_Tool result:_
```
                 medication           charttime                 event_txt
           Fentanyl Citrate 2158-06-30 00:57:00              Administered
                  CeFAZolin 2158-06-30 01:49:00                   Started
                        nan 2158-06-30 01:49:00                   Started
                  CeFAZolin 2158-06-30 02:19:00 Stopped in Other Location
                    Heparin 2158-06-30 02:37:00              Administered
           Acetaminophen IV 2158-06-30 05:25:00              Administered
                        nan 2158-06-30 05:33:00                   Started
   HYDROmorphone (Dilaudid) 2158-06-30 06:01:00              Administered
   HYDROmorphone (Dilaudid) 2158-06-30 06:48:00              Administered
                        nan 2158-06-30 09:13:00                 Confirmed
Sodium Chloride 0.9%  Flush 2158-06-30 09:13:00                   Flushed
                  CeFAZolin 2158-06-30 10:10:00              Administered
              MetroNIDAZOLE 2158-06-30 11:05:00              Administered
           Acetaminophen IV 2158-06-30 12:49:00              Administered
   HYDROmorphone (Dilaudid) 2158-06-30 15:29:00              Administered
                        nan 2158-06-30 16:40:00                 Confirmed
Sodium Chloride 0.9%  Flush 2158-06-30 16:40:00                   Flushed
                        nan 2158-06-30 17:33:00                   St
…[truncated 893 chars]
```

### 2. [MISLEADING] Call #57: `browser.search` — Search results about empiric antibiotics for intra-abdominal infections mentioning metronidazole

**Why this call determined the answer:** Agent used clinical guidelines suggesting metronidazole for intra-abdominal infections to override the actual pyxis dispensing pattern already visible in the data.

_Tool call:_ `browser.search({"query": "vancomycin piperacillin-tazobactam metronidazole intra-abdominal infection ED empiric antibiotics", "topn": 5})`

_Tool result:_
```
[0] vancomycin piperacillin-tazobactam metronidazole intra-abdominal infection ED empiric antibiotics (web-search://ts=1776909076)
**viewing lines [0 - 42] of 42**

L0: 
L1: URL: web-search://ts=1776909076
L2: # Search Results
L3: 
L4:   * 【0†Antimicrobial management of intra-abdominal infections - PMC - 
L5: NIH†pmc.ncbi.nlm.nih.gov】 Antimicrobial management of severe intra-abdominal 
L6: infections (IAIs) involves a delicate balance of optimizing empirical therapy, 
L7: which has been shown to ...
L8:   * 【1†Updated Guideline on Diagnosis and Treatment of Intra-abdominal 
L9: ...†www.aafp.org】 Antibiotics that can be used against this organism include 
L10: ampicillin, piperacillin/tazobactam, and vancomycin. Empiric therapy for 
L11: vancomycin ...
L12:   * 【2†Abdominopelvic Infections | Infectious Diseases ... - UCSF 
L13: IDMP†idmp.ucsf.edu】 Abdominal Infections ; Vancomycin. PLUS one of ; tazobactam.
L14:  OR.
L15:   * 【3†[PDF] Empiric Treatment Guidelines for Common Infections in 
L16: Adults†physicians.northernhealth.ca】 Intra-abdominal Infection. Clinical Key 
L17: Points. • When culture ... Piperacillin-Tazobactam 3.375 g IV q6h +/- 
L18: Gentamicin/Tobramycin 5 to 7 mg/kg (IBW) IV ...
L19:   * 【4†Diagnosis and Management of Complicated Intra-abdominal 
L20: ...†academic.oup.com】 Comparison of intravenous/ oral ciprofloxacin plus 
L21: metronidazole versus piperacilli
…[truncated 1416 chars]
```

### 3. [MISLEADING] Call #58: `browser.open` — UCSF guideline listing metronidazole as part of empiric regimen for peritonitis

**Why this call determined the answer:** Agent used this guideline to justify predicting metronidazole as next pyxis item instead of following the actual dispensing sequence in the EHR.

_Tool call:_ `browser.open({"id": "2"})`

_Tool result:_
```
[1] Abdominopelvic Infections | Infectious Diseases Management Program at UCSF (https://idmp.ucsf.edu/guidelines-empiric-therapy-categories/abdominopelvic-infections)
**viewing lines [0 - 49] of 103**

L0: 
L1: URL: https://idmp.ucsf.edu/guidelines-empiric-therapy-categories/abdominopelvic-
L2: infections
L3: Abdominopelvic Infections Abdominal Infections Patient Population: Adult See 
L4: Pelvic Inflammatory disease for that syndrome Diagnosis Common Pathogens Drug(s)
L5:  of First Choice Alternative Drug(s) Comments Expected Duration Community-
L6: acquired secondary peritonitis E. coli Ceftriaxone PLUS For severe beta-lactam 
L7: allergy: Stop antibiotics 4 days after source control achieved Mild-moderate 
L8: intra-abdominal abscess (community acquired) Klebsiella Metronidazole Vancomycin
L9:  PLUS If source control is not obtained, consultation with ID recommended B. 
L10: fragilis Aztreonam PLUS Streptococci spp Metronidazole Healthcare-associated 
L11: secondary peritonitis Community pathogens Piperacillin/tazobactam For severe PCN
L12:  allergy: Fungal coverage rarely needed empirically but consider in Stop 
L13: antibiotics 4 days after source control achieved high-risk patients: critically 
L14: ill with upper GI source, Mild-Moderate intra-abdominal abscess (including post-
L15: op PLUS OR VancomycinPLUS recurrent bowel perforation, heavy colonization, If 
L16: sourc
…[truncated 2767 chars]
```

### 4. [MISLEADING] Call #52: `ehr.run_sql_query` — Prior admission prescriptions showing MetroNIDAZOLE IV 500mg during June hospitalization

**Why this call determined the answer:** Agent extrapolated from prior admission's antibiotic regimen to predict current pyxis dispense, ignoring that piperacillin-tazobactam was already pulled.

_Tool call:_ `ehr.run_sql_query({"subject_id": "14290863", "sql_query": "SELECT drug, route, starttime, stoptime, dose_val_rx, dose_unit_rx FROM prescriptions WHERE hadm_id = 23137539 ORDER BY starttime"})`

_Tool result:_
```
                                    drug     route           starttime            stoptime dose_val_rx dose_unit_rx
                                      NS        IV 2158-06-30 09:00:00 2158-07-02 01:00:00         100           mL
                           MetroNIDAZOLE        IV 2158-06-30 09:00:00 2158-07-02 01:00:00         500           mg
              Lidocaine Jelly 2% (Glydo)        TP 2158-06-30 09:00:00 2158-07-01 08:00:00           1         Appl
                        Lactated Ringers        IV 2158-06-30 09:00:00 2158-06-30 18:00:00        1000           mL
             Sodium Chloride 0.9%  Flush        IV 2158-06-30 09:00:00 2158-07-06 19:00:00        3-10           mL
                    Iso-Osmotic Dextrose        IV 2158-06-30 09:00:00 2158-07-02 01:00:00         100           mL
                               CeFAZolin        IV 2158-06-30 09:00:00 2158-07-02 01:00:00           2            g
                HYDROmorphone (Dilaudid)        IV 2158-06-30 09:00:00 2158-06-30 14:00:00        0.25           mg
                        Acetaminophen IV        IV 2158-06-30 09:00:00 2158-07-01 09:00:00        1000           mg
          Influenza Vaccine Quadrivalent        IM 2158-06-30 09:00:00 2158-07-03 14:00:00         0.5           mL
                HYDROmorphone (Dilaudid)        IV 2158-06-30 15:00:00 2158-07-04 10:00:00        0.25           mg
        
…[truncated 3355 chars]
```

### 5. [IGNORED] Call #3: `ehr.get_latest_records` — Pyxis shows Piperacilli 4.5g/100mL 100mL BAG dispensed at 18:56 with med_rn=3

**Why this call determined the answer:** Agent saw this data but interpreted the task as predicting a NEW medication not yet dispensed, rather than the next suggestion from already-dispensed items.

_Tool call:_ `ehr.get_latest_records({"subject_id": "14290863", "table_name": "pyxis"})`

_Tool result:_
```
 stay_id           charttime med_rn                             name gsn_rn     gsn
38692269 2158-09-05 18:56:00      2 Vancomyci 1000mg/200mL 200mL BAG      1  9329.0
38692269 2158-09-05 18:56:00      2 Vancomyci 1000mg/200mL 200mL BAG      2 43952.0
38692269 2158-09-05 18:56:00      3 Piperacilli 4.5g/100mL 100mL BAG      1 21187.0
38692269 2158-09-05 18:56:00      3 Piperacilli 4.5g/100mL 100mL BAG      2 40819.0
```

### 6. [IGNORED] Call #49: `ehr.run_sql_query` — Full pyxis for stay 38692269 shows Vancomycin and Piperacillin already dispensed at 18:56

**Why this call determined the answer:** Agent had the complete pyxis record but chose to predict a medication not in the pyxis, reasoning clinically rather than following dispensing patterns.

_Tool call:_ `ehr.run_sql_query({"subject_id": "14290863", "sql_query": "SELECT * FROM pyxis WHERE stay_id = 38692269 ORDER BY charttime"})`

_Tool result:_
```
 stay_id           charttime med_rn                             name gsn_rn     gsn
38692269 2158-09-05 17:59:00      1 Readi-Cat 2  (Barium S 450mL BTL      1 19661.0
38692269 2158-09-05 17:59:00      1 Readi-Cat 2  (Barium S 450mL BTL      2 77720.0
38692269 2158-09-05 18:56:00      2 Vancomyci 1000mg/200mL 200mL BAG      1  9329.0
38692269 2158-09-05 18:56:00      2 Vancomyci 1000mg/200mL 200mL BAG      2 43952.0
38692269 2158-09-05 18:56:00      3 Piperacilli 4.5g/100mL 100mL BAG      1 21187.0
38692269 2158-09-05 18:56:00      3 Piperacilli 4.5g/100mL 100mL BAG      2 40819.0
```

## Analyzer root-cause summary

> The agent saw Piperacillin-Tazobactam already dispensed in pyxis at 18:56 but misunderstood the task as predicting a new, undispensed medication. It used prior admission history and clinical guidelines about intra-abdominal infections to predict MetroNIDAZOLE instead of recognizing the next pyxis suggestion was the already-dispensed Piperacillin.

## ClinSeek final `ehr.think` synthesis (head)
```
Let me synthesize all the information gathered:

**Patient Profile:**
- 91-year-old male with B-cell lymphoma (on chemotherapy), HTN, pulmonary hypertension, BPH
- Recent surgical history: bowel obstruction → exploratory laparotomy/small bowel resection (June 30), then wound dehiscence → fascial closure revision (July 11)
- Now presenting (Sept 5) with abdominal distention, low-grade fever (99°F), pain 5/10

**Current ED Course (stay_id 38692269, in ED from 14:45):**
- Triage: temp 99.0, HR 89, RR 16, O2 99%, BP 174/79
- Vitals at 17:26: temp 98.0, HR 69, RR 16, O2 98%, BP 141/58
- Labs: WBC 14.1 (elevated), neutrophils 92% (high), lymphocytes 3% (very low, absolute 0.42 - immunosuppressed), Hgb 11.1 (anemic), Na 130 (low), Cl 94 (low)
- Wound culture collected at 17:46 (later grew MSSA)
- Blood cultures collected at 16:00 and 18:00
- CT with oral contrast (barium at 17:59)
- Two medication orders at 18:48:56

**ED Pyxis pulls so far:**
1. Readi-Cat 2 (barium) at 17:59
2. Vancomycin 1000mg/200mL BAG at 18:56
3. Piperacillin-Tazobactam 4.5g/100mL BAG at 18:56

**Clinical Assessment:**
- Patient has suspected intra-abdominal/wound infection (recurrent surgical complication)
- Broad-spectrum empiric antibiotics started (Vanc + Pip-Tazo)
- Being admitted to Surgery observation
- Immunocompromised (lymphoma, chemo, absolute lymphocyte count 0.42)

**Prior admission pattern:** First admission used CeFAZolin + MetroNIDAZole for intra-abdominal infection

**Prediction Reasoning:**
The candidate list is predominantly antibiotics. Given:
1. The patient's prior use of MetroNIDAZole for similar pathology
2. The immunocompromised status warranting aggressive empiric coverage
3. Complex surgical history with recurrent abdominal complications
4. The pattern of adding MetroNIDAZole for enhanced anaerobic/C. diff coverage in severe infections

The most likely next ED Pyxis medication is MetroNIDAZole, which provides additional anaerobic tissue penetration and C. difficile coverage i
…[truncated 25 chars]
```

## Full reasoning-mode output
```
Looking at the patient timeline, I need to determine what the next ED Pyxis dispensation would be.

The patient is a 91-year-old male presenting with abdominal distention. He has a history of recent abdominal surgeries, wound dehiscence, and B-cell lymphoma.

Key events:
1. At 17:59, Readi-Cat 2 (barium) was dispensed from Pyxis (for CT scan prep)
2. At 18:48, medication orders were placed
3. At 18:56, Vancomycin 1000mg/200mL and Piperacillin 4.5g/100mL were dispensed from Pyxis (two of each)
4. At 19:00, Vancomycin was started (administered)

The Vancomycin has already been started. The next step would be to administer the Piperacillin-Tazobactam that was already pulled from Pyxis at 18:56. However, the question asks for the next **Pyxis** suggestion, meaning what would next be dispensed from the Pyxis machine.

Looking at the pattern - the patient has been started on broad-spectrum antibiotics (Vancomycin + Piperacillin-Tazobactam) for what appears to be an intra-abdominal/wound infection. The Piperacillin-Tazobactam was already pulled from Pyxis but the next Pyxis pull would likely be related to ongoing care.

Given the patient's presentation (abdominal distention, pain score of 5, history of surgical complications), and that the antibiotics have been dispensed, the next Pyxis pull would likely be the Piperacillin-Tazobactam for administration, or additional supportive medications.

Since both Vancomycin and Piperacillin-Tazobactam were already pulled at 18:56, and Vancomycin was started at 19:00, the Piperacillin-Tazobactam would be administered next. But for the next *Pyxis* dispensation, looking at the candidates and the clinical context, the most logical next Pyxis pull would be related to the Piperacillin-Tazobactam administration or a subsequent dose.

Given the candidates, the answer that best fits is:

<answer>Piperacilli 4.5g/100mL 100mL BAG</answer>
```